<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>COVID-19 treatment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/covid-19-treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 18:31:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>COVID-19 treatment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Tiprelestat: Breakthrough in Hospitalized COVID-19 Treatment</title>
		<link>https://bioengineer.org/tiprelestat-breakthrough-in-hospitalized-covid-19-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 18:31:16 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[akciğer iltihabı]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[COVID-19 tedavisi]]></category>
		<category><![CDATA[COVID-19 treatment]]></category>
		<category><![CDATA[hastanede yatan hastalar]]></category>
		<category><![CDATA[hospitalized patients]]></category>
		<category><![CDATA[klinik çalışma]]></category>
		<category><![CDATA[Tiprelestat]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tiprelestat-breakthrough-in-hospitalized-covid-19-treatment/</guid>

					<description><![CDATA[In a significant advance for COVID-19 treatment, recent findings emerged from the double-blind randomized placebo-controlled COMCOVID trial, which evaluated the efficacy of Tiprelestat in hospitalized patients. Researchers aimed not only to assess the drug’s impact on the illness but also to glean insights into its broader implications for managing severe COVID-19 cases. This essential research [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318499</post-id>	</item>
		<item>
		<title>Repurposing Pyronaridine for COVID-19: Targeted Therapy Insights</title>
		<link>https://bioengineer.org/repurposing-pyronaridine-for-covid-19-targeted-therapy-insights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 10 Dec 2025 11:00:04 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Antiviral therapy]]></category>
		<category><![CDATA[COVID-19 treatment]]></category>
		<category><![CDATA[Drug repurposing** **Açıklama:** 1. **Pyronaridine repurposing:** Çalışmanın temel konusu]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **Pyronaridine repurposing]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **Pyronaridine repurposing]]></category>
		<category><![CDATA[Pharmacokinetic modeling]]></category>
		<category><![CDATA[sıtma ilacı pyronaridine'in COVID-19 için yeniden kullanımını araştırm]]></category>
		<category><![CDATA[Target organ exposure** **Kısa açıklama:** 1. **Pyronaridine repurposing:** Makalenin temel konusu olan sıtma ilacı pyronaridine'in COVID-19 için yeniden kullanımı. 2. **COVID-19]]></category>
		<guid isPermaLink="false">https://bioengineer.org/repurposing-pyronaridine-for-covid-19-targeted-therapy-insights/</guid>

					<description><![CDATA[In the wake of the COVID-19 pandemic, the scientific community has been mobilizing its efforts to identify effective treatments that can curb the severity of the disease while also being feasible for widespread use. One divergent pathway that researchers have explored is the repurposing of existing drugs for new therapeutic indications. In this pressing context, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">304876</post-id>	</item>
	</channel>
</rss>
